The government work report mentions innovative drugs for the first time. The pharmaceutical industry generally believes that this is a national-level effort to promote China's transformation from a large pharmaceutical production country to a powerful pharmaceutical country.

Since 2011, China has approved more than 500 new drugs for marketing. There are more than 3,500 new drug projects under development, accounting for 33% of the world's total. There were 44 cases of multinational companies purchasing R&D projects of Chinese companies in 2022. Since 2023, there have been more than 70 cases, with a transaction volume of nearly more than US$40 billion.